国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

World / US and Canada

Canadian Ebola vaccine begins human testing

(Agencies) Updated: 2014-10-14 09:59

TORONTO - Human testing of an experimental Canadian-made Ebola vaccine began Monday, with federal officials saying the drug could be shipped to West Africa within months if it proves successful.

Health Minister Rona Ambrose said the launch of the vaccine's first clinical trial marks a promising step in the global campaign to contain the virus, which the World Health Organization says has killed more than 4,000 people, mostly in the West African countries of Liberia, Sierra Leone and Guinea.

"This provides hope because if the Canadian vaccine is shown to be safe and effective, it will stop this devastating outbreak," Ambrose said in a conference call from Calgary.

Twenty vials of the vaccine have been sent to the Walter Reed Army Institute of Research in Maryland for testing on about 40 healthy volunteers, she said.

The Phase 1 trial will determine if the vaccine created by Public Health Agency of Canada and known as VSV-EBOV is safe for human use. It will also determine the proper dosage level and test for possible side effects, Ambrose said.

Studies have shown the vaccine works in primates both to prevent infection when given before exposure and to increase survival chances when given quickly after exposure.

Canada's chief public health officer said results from the human trial are expected by December, and if successful, the next stage would be to test it in a larger human sample, including those directly handling Ebola cases in West Africa.

"The health-care workers on the ground are the most likely target to do the next step," which could begin by the end of the year or early 2015, Dr. Gregory Taylor said in a news conference in Toronto.

A small US company called NewLink Genetics holds the licence for the vaccine and will be arranging the trials at the US military lab.

NewLink said earlier this month that at least five clinical trials involving the vaccine would soon be underway in the United States, Germany, Switzerland and in an unnamed African country which is not battling Ebola. The Canadian government has also said it wants to conduct a trial in this country.

The aim of these early trials is to see if the vaccine is safe for human use and how much vaccine is needed to generate what is hoped to be a protective response in people.

Trudeau visits Sina Weibo
May gets little gasp as EU extends deadline for sufficient progress in Brexit talks
Ethiopian FM urges strengthened Ethiopia-China ties
Yemen's ex-president Saleh, relatives killed by Houthis
Most Popular
Hot Topics

...
林口县| 宽城| 阳朔县| 南岸区| 韶山市| 鄂托克前旗| 龙山县| 德清县| 岐山县| 通州市| 离岛区| 郓城县| 广平县| 招远市| 巩留县| 固镇县| 尼木县| 鄂伦春自治旗| 麦盖提县| 渑池县| 谢通门县| 宣城市| 兴义市| 满城县| 舒城县| 岳池县| 平安县| 通河县| 舞阳县| 贺州市| 宾川县| 谢通门县| 土默特左旗| 仙桃市| 和硕县| 张家口市| 亳州市| 原阳县| 桑植县| 巫溪县| 大邑县|